SGP - Spyglass Pharma, Inc.

Insider Purchase by Pardo Geoffrey B (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

1 week ago, Pardo Geoffrey B, serving as Dir at Spyglass Pharma, Inc. (SGP), purchased 312,500 shares at $16.00 per share, for a total transaction value of $5,000,000.00. Following this transaction, Pardo Geoffrey B now holds 2,187,513 shares of SGP.

This purchase represents a 17.00% increase in Pardo Geoffrey B's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, February 9, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 11, 2026, 2 days after the trade was made.

Pardo Geoffrey B

Pardo Geoffrey B

Dir

Geoffrey B. Pardo is a seasoned medtech investor and executive serving as an Independent Director at Shoulder Innovations, Inc. (SI) since 2023.[[1]](https://shoulderinnovations.com/leadership-team/)[[5]](https://gildehealthcare.com/team/venture-and-growth/geoff-pardo/)[[6]](https://ca.marketscreener.com/insider/GEOFF-B-PARDO-A091CI/) He recently purchased 100,000 shares of Shoulder Innovations at $15 per share, investing approximately $1.5 million, signaling strong confidence in the company.[[3]](https://www.waiker.ai/data-lab/waiker-news/6255)[[4]](https://www.quiverquant.com/news/SHOULDER+INNOVATIONS+Earnings+Results:+$SI+Reports+Quarterly+Earnings) Pardo joined Gilde Healthcare in 2011 as a Partner (now General Partner) in their Boston/Cambridge office, leading investments in North America including Inari Medical (NASDAQ: NARI), Axonics (NASDAQ: AXNX), CVRx, and Shoulder Innovations.[[2]](https://medtechmvp.com/biographies/Geoff-Pardo)[[5]](https://gildehealthcare.com/team/venture-and-growth/geoff-pardo/) Previously, he was President & CEO of Facet Solutions, a spinal implant company treating lumbar spinal stenosis, until its sale to Globus Medical in 2011; Partner at Spray Venture Partners, leading deals like Interlace Medical (sold to Hologic); and an Associate at Cardinal Partners.[[1]](https://shoulderinnovations.com/leadership-team/)[[2]](https://medtechmvp.com/biographies/Geoff-Pardo) He began his career as a product manager at Synthes USA and holds a BA with honors in History from Brown University and an MBA from The Wharton School.[[1]](https://shoulderinnovations.com/leadership-team/)[[2]](https://medtechmvp.com/biographies/Geoff-Pardo)

View full insider profile →

Trade Price

$16.00

Quantity

312,500

Total Value

$5,000,000.00

Shares Owned

2,187,513

Trade Date

Monday, February 9, 2026

13 days ago

SEC Filing Date

Wednesday, February 11, 2026

Filed 2 days after trade

About Spyglass Pharma, Inc.

Company Overview

No company information available
View news mentioning SGP

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/3897851

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime